BIIB vs COO · P/E 21, rev $9.89B vs P/E 36, rev $4.09B
Biogen Inc (BIIB) versus The Cooper Companies, Inc (COO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Not investment advice. Open the BIIB and COO stock pages for the full models.
Not investment advice.